Vyne Therapeutics Inc (VYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,100 | 42,855 | 52,911 | 104,011 | 119,371 |
| Marketable Securities | N/A | N/A | 0 | N/A | 1,027 |
| Receivables | 535 | 7,583 | 10,084 | 10,868 | 10,755 |
| Inventories | N/A | N/A | 8,070 | 8,279 | 8,092 |
| Other current assets | 5,124 | 8,183 | 0 | 0 | 0 |
| TOTAL | $60,654 | $63,186 | $76,129 | $128,426 | $143,117 |
| Non-Current Assets | |||||
| PPE Net | 310 | 354 | 472 | 501 | 529 |
| Other Non-Current Assets | 3,355 | 3,506 | 4,714 | 5,056 | 5,525 |
| TOTAL | $3,665 | $3,860 | $5,186 | $5,557 | $6,054 |
| Total Assets | $64,319 | $67,046 | $81,315 | $133,983 | $149,171 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 33,375 | N/A |
| Accounts payable and accrued liabilities | 3,612 | 6,510 | 7,621 | 10,080 | 3,490 |
| Accrued Expenses | 3,312 | 8,593 | 9,613 | 10,146 | 13,521 |
| Other current liabilities | 1,331 | 2,958 | 3,486 | 3,585 | 3,891 |
| TOTAL | $8,255 | $18,410 | $20,997 | $57,620 | $21,549 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 33,274 |
| Other Non-Current Liabilities | 333 | 0 | 1,432 | 1,470 | 1,447 |
| TOTAL | $333 | $N/A | $1,432 | $1,470 | $34,721 |
| Total Liabilities | $8,588 | $18,410 | $22,429 | $59,090 | $56,270 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,220 | 3,123 | 2,976 | 2,864 | 2,857 |
| Common Shares | 6 | 5 | 5 | 5 | 5 |
| Retained earnings | -634,855 | -639,525 | -627,955 | -606,670 | -586,746 |
| TOTAL | $55,731 | $48,636 | $58,886 | $74,893 | $92,901 |
| Total Liabilities And Equity | $64,319 | $67,046 | $81,315 | $133,983 | $149,171 |